BioSpace News Archive

- Data presented show maintained or improved responses in multiple efficacy endpoints among patients treated with sotatercept plus stable background therapy for up to 48 weeks - - Patients receiving placebo plus stable background therapy during the 24-week placebo-controlled period who were re-randomized to sotatercept plus stable background therapy during weeks 24 to 48 experienced improvements

– Treatment with sotatercept in the ongoing SPECTRA Phase 2 trial was associated with improvements in resting and exercise hemodynamics at week 24 – – Sotatercept was generally well tolerated, consistent with the previously reported safety profile in PAH and in other diseases – - Company-hosted investor and analyst conference call and webcast with guest PAH key opinion leader to be held today, Wednesday, May 19th at 10:30 a.m. EDT –

Industry veteran departs bioMérieux to lead the commercialization of Qvella’s lineup of products starting with FAST-Prep, an automated cartridge-based system for Positive Blood Culture (PBC) processing

Leading European pharmaceutical companies are using the device across multiple virtual clinical trials to gather unprecedented amounts of pharmacokinetic data

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (“Lighthouse”).

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed Tomography 7500.

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will be participating in a fireside chat at the Jefferies Virtual Healthcare Conference on June 3, 2021 and will be hosting virtual one-on-one meetings with investors during the conference.

Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced the appointment of Dan Stewart as Vice President and General Manager of the company’s International business.

Global health service company Cigna Corporation announced that Tim Wentworth, chief executive officer of Evernorth, will present at the Goldman Sachs 42nd Annual Healthcare Conference on June 9, 2021 through a virtual webcast.

Therapeutic Solutions International, Inc., has announced that the internationally renowned transactional lawyer, Mr. Kenji Funahashi, Partner at Wilson Sonsini, has joined its advisory board.